-
To review and approve post-marketing Individual Case Safety Reports (ICSRs) and Serious Adverse Event (SAE) reports occurring in clinical trials for medical/causality assessment. The review includes coding, seriousness assessment, Company causality and comment, listedness/expectedness and follow-up questions.
-
To act as a Qualified Person for Pharmacovigilance or support the Qualified Person for Pharmacovigilance (if not medically qualified) in the medical understanding and evaluation of any safety issues
-
To review and provide input in Periodic Safety Update Reports, Development Safety Update Reports, literature screening search strategy
-
To review articles to determine if they contain ICSRs/SAEs related to the relevant Medicinal Product or other safety related findings
-
To cooperate in the preparation of and provide input in Risk Management Plans
-
Supporting the preparation of responses to regulatory authority requests
-
Signalling
-
Reviewing line listings
-
Participating in signal detection activities including meetings, writing signal detection reports if applicable if required, and providing consultation to clients on aspects related to benefit/risk assessment and risk minimisation
-
Evaluating and categorizing possible signals and proposing a course of action
-
Supporting preparation and review of benefit-risk reports